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Abstract
Synchronous double cancers consisting of hepatocellular carcinoma (HCC) and cholangiolocellular carcinoma
(CoCC) are extremely rare. We herein report a surgical case of synchronous double cancers in a patient with
primary HCC and CoCC. A 45-year-old man with hepatitis B was admitted to our hospital with hepatic
tumors. The level of protein induced by vitamin K antagonist (PIVKA-II) was found to be elevated. Computed
tomography (CT) revealed a 23-mm tumor with early-phase enhancement and late-phase washout in the 6th
segment of the liver, and a 10-mm tumor with slight early-phase enhancement and late-phase washout in
the 7th segment of the liver. Magnetic resonance imaging (MRI) revealed that the two tumors in the 6th and
7th segments showed low intensity on T1-weighted images and high intensity on T2-weighted images. Based
on those preoperative examinations, the liver tumors were diagnosed as multiple primary hepatocellular
carcinomas. The patient underwent a posterior segmentectomy. A histopathological examination revealed that
the tumor of the 6th segment of the liver was moderately differentiated HCC, and that the tumor of the 7th
segment of the liver was CoCC. The postoperative course was uneventful. However, lymph node recurrence
was observed 6 months later and the patient died 20 months after surgery. There are only six reported
surgical cases of synchronous double primary liver cancers consisting of HCC and CoCC. We are of the
opinion that curative resection may be an effective treatment for double cancer consisting of HCC and CoCC,
and that it may provide long-term survival.
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Background
The incidence of synchronous double cancers consisting
of different primary hepatic tumors is very low. Most
cases involve patients with double cancers consisting of
hepatocellular carcinoma (HCC) and intrahepatic cho-
langiocellular carcinoma (CCC). Cholangiolocellular car-
cinoma (CoCC) is a rare form of primary liver cancer
that was first proposed by Steiner and Higginson in
1959 [1]. There are only five other reported cases of syn-
chronous double primary liver cancers consisting of
HCC and CoCC [2–6]. We herein report a surgical case
of synchronous double cancers in a patient with primary
HCC and CoCC and review the literature.
Case presentation
A 45-year-old man with hepatitis B was admitted to our
hospital because of hepatic tumors. He was administered
a daily dose of 0.5 mg entecavir. He had a history of
treatment for esophageal varices. The results of a
physical examination were normal. A laboratory
examination produced the following results: white
blood cell count, 3000/μl; red blood cell count, 473 ×
104/μl; hemoglobin, 13.1 g/dl; platelet count, 8.7 ×
104/μl; albumin, 4.5 g/dl; total bilirubin, 1.7 mg/dl; and
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prothrombin time (percent), 79%. The alanine amino-
transferase, aspartate aminotransferase, alkaline phosphat-
ase, lactate dehydrogenase, and γ-glutamyl transpeptidase
levels were within the normal ranges. The indocyanine
green retention value at 15 min was 34%. The patient was
hepatitis B virus-related antigen (HBsAg)-positive and
HBs antibody (HBsAb)- and hepatitis C virus antibody
(HCVAb)-negative. The serum HBV-DNA was not
detected. The level of protein induced by vitamin K antag-
onist (PIVKA-II) was found to be elevated (317 mAU/ml),
but the level of alpha-fetoprotein (AFP) was within the
normal limits.
Abdominal ultrasonography (US) showed a well-
defined 23-mm hypoechoic mass that was heterogeneous
on the inside in the 6th segment of the liver (Fig. 1a),
and a slightly ill-defined 10-mm hypoechoic mass that
was homogeneous on the inside in the 7th segment of
the liver (Fig. 1b). Abdominal computed tomography
(CT) revealed a 23-mm tumor with early phase-
enhancement and late-phase washout in the 6th segment
of the liver (Fig. 2a, b), and a 10-mm tumor with slight
early-phase enhancement and late-phase washout in
the 7th segment of the liver (Fig. 2c, d). Abdominal
magnetic resonance imaging (MRI) revealed that the
two tumors in the 6th (Fig. 3a, b) and 7th (Fig. 3c, d)
segments showed low intensity on T1-weighted im-
ages and high intensity on T2-weighted images. Based
on these preoperative examinations, the liver tumors
were diagnosed as multiple primary hepatocellular
carcinomas. The patient underwent a posterior
segmentectomy. We did not perform lymph node
dissection, because we diagnosed multiple primary he-
patocellular carcinomas preoperatively. The resected
specimen showed that the tumor of the 6th segment
of the liver was a 23-mm well-defined yellowish-white
soft elastic lesion (Fig. 4a), and that the tumor of the
7th segment was a 10-mm irregular yellowish-white
slightly hard elastic lesion (Fig. 4b). A histopatho-
logical examination revealed that the tumor of the
6th segment of the liver was moderately differentiated
hepatocellular carcinoma (Fig. 5a), while that of the 7th
segment was cholangiolocellular carcinoma (Fig. 5b). The
pathological findings of the non-cancerous tissue were
liver cirrhosis. An immunohistochemical examination of
the tumor cells in the 7th segment of the liver was positive
a
b
Fig. 1 Abdominal ultrasonography (US) showed the two tumors.
a A well-defined 23-mm hypoechoic mass that was heterogeneous
on the inside was observed in the 6th segment of the liver
(arrows). b A slightly ill-defined 10-mm hypoechoic mass that




Fig. 2 Abdominal computed tomography (CT) of the two tumors.
a A 23-mm tumor had early-phase enhancement in the 6th segment
of the liver (arrow). b The tumor showed late-phase washout in the
6th segment of the liver (arrow). c A 10-mm tumor showed slight
early-phase enhancement in the 7th segment of the liver (arrow).
d The tumor showed late-phase washout in the 7th segment of the
liver (arrow)
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for CK7, CK19, EMA, and MUC1/DF3 and was negative
for EpCAM (Fig. 5c–g).
The postoperative course was uneventful and the pa-
tient was discharged on postoperative day 25. However,
6 months later, lymph node recurrence of the hepato-
duodenal ligament was observed. The patient died of
multiple organ failure due to cancer recurrence
20 months after surgery.
Discussion
HCC and CCC are the two main primary liver cancers.
CoCC is a rare form of primary liver cancer. In 1959,
Steiner and Higginson described the distinct patho-
logical characteristic of CoCC, which is derived from
the cholangioles or canals of Hering [1]. The tumor
was classified as a special type of CCC [7, 8]. How-
ever, as a result of recent advances in the study and
knowledge of hepatic progenitor or stem cells, CoCC
is considered to originate from hepatic progenitor or
stem cells [9–12].
The occurrence of synchronous double cancers con-
sisting of different primary hepatic tumors is very
low. Combined HCC and CCC is a rare primary liver
tumor, and the reported incidence of combined HCC
and CCC among pathologically diagnosed primary
liver cancers was only 0.54% [13]. Allen and Lisa de-
fined three types of HCC-CCC: (a) HCC and CCC
are present at different sites within the same liver
(double cancer type), (b) HCC and CCC are present
at adjacent sites and mingle with each other but are
still recognizable as distinct tumors (combined type),
and (c) HCC and CCC components combined within
the same tumor and indistinguishable as separate en-
tities (mixed type) [14]. In the present case, we diag-
nosed a double cancer consisting of HCC and CoCC
because the tumors were present at different sites
within the same liver.
There are only six reports of double cancer consisting
of HCC and CoCC, including our case (Table 1) [2–6].
The patients in these cases were from 45 to 71 years of
age (average 65 years); five of the patients were male and
one was female. Two of the six patients were HCVAb-
positive, two were HBsAg-positive, and two were
HBsAb-positive. In all of the six cases, the AFP or
PIVKA-II levels were found to be elevated, but the level
of carcinoembryonic antigen (CEA) or carbohydrate
antigen 19-9 (CA19-9) was not. The average sizes of the
a b
c d
Fig. 3 Abdominal magnetic resonance imaging (MRI) of the two
tumors. a The tumor in the 6th segment of the liver showed low
intensity on T1-weighted images (arrow). b The tumor in the 6th
segment of the liver showed high intensity on T2-weighted images
(arrow). c The tumor in the 7th segment of the liver showed low
intensity on T1-weighted images (arrow). d The tumor in the 7th
segment of the liver showed high intensity on T2-weighted
images (arrow)
Fig. 4 The resected specimen showed two tumors. a The tumor of the
6th segment of the liver was a 23-mm well-defined yellowish-white soft
elastic lesion. b The tumor of the 7th segment of the liver was a 10-mm
irregular yellowish-white slightly hard elastic lesion
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CoCC and HCC tumors (in greatest dimension) were
1.6 cm (range 0.8–2.2) and 2.8 cm (range 1.2–4.5), re-
spectively. In the histopathological examinations of the
non-cancerous portion of the liver, three patients had
chronic hepatitis and two patients had liver cirrhosis.
The preoperative diagnosis of CoCC is extremely diffi-
cult using US, CT, and MRI. CoCC has been misdiag-
nosed as HCC, CCC, and metastatic liver cancer.
Recently, some reports have examined the imaging find-
ings in cases of CoCC [15, 16]. US shows a hypoechoic
mass, CT shows uniform and complete enhancement or
peripheral ring-like enhancement, and MRI shows isoin-
tensity or low intensity on T1-weighted images and high
intensity on T2-weighted images. In our case, US
showed a hypoechoic mass, CT showed slight early-
phase enhancement and late-phase washout, and MRI
Fig. 5 The histopathological examination of the two tumors. a The tumor of the 6th segment of the liver was moderately differentiated
hepatocellular carcinoma (Hematoxylin and eosin staining, ×200). b The tumor of the 7th segment of the liver was cholangiolocellular carcinoma
(Hematoxylin and eosin staining, ×200). c The immunohistochemical examination of tumor cells from the 7th segment of the liver revealed that
they were CK7 positive (×200). d The immunohistochemical examination of tumor cells from the 7th segment of the liver revealed that they were
CK19 positive (×200). e The immunohistochemical examination of tumor cells from the 7th segment of the liver revealed that they were EMA
positive (×200). f The immunohistochemical examination of tumor cells from the 7th segment of the liver revealed that they were MUC1/DF3
positive (×200). g The immunohistochemical examination of tumor cells from the 7th segment of the liver revealed that they were EpCAM
negative (×200)
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showed low intensity on T1-weighted images and high
intensity on T2-weighted images. However, we misdiag-
nosed CoCC as HCC.
A previous report indicated that the most frequent site
of recurrence in surgically resected CoCC is the liver,
and that no lymph node recurrence was seen [17]. Our
case was the only case to show lymph node recurrence
among the six reported cases of double cancer consisting
of HCC and CoCC.
Ariizumi et al. [17] reported that the 5-year survival
rate for patients who underwent curative surgery was
significantly higher in the CoCC (75%) than in the intra-
hepatic CCC (33%). Among the six reported patients
who underwent curative resection for double cancer
consisting of HCC and CoCC, five patients remained
alive without recurrence at the time of the publication of
the report; the only exception was our patient. There-
fore, curative resection may be an effective treatment for
double cancer consisting of HCC and CoCC and may
provide long-term survival.
Conclusions
We reported a case of double primary HCC and CoCC.
Synchronous double cancers consisting of HCC and
CoCC are extremely rare, with only six reported cases of
resected double cancer consisting of HCC and CoCC in
the literature, including our own. We are of the opinion
that curative resection may be an effective treatment for
double cancer consisting of HCC and CoCC, and that it
may provide long-term survival.
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